---
figid: PMC4136419__nihms603930f2
figlink: /pmc/articles/PMC4136419/figure/F2/
number: F2
caption: Pro-B cells (Fraction B) proliferate under the influence of the IL7 receptor
  (activation of JAK-STAT5, AKT) until they rearrange Ig VH-DJH gene segments to express
  a functional μ heavy chain (μ HC) as part of the pre-BCR (Fraction C’). Upon initial
  cell surface expression (Fraction C’), autonomous pre-BCR signaling induces strong
  proliferation via activation of SRC kinases (Lyn), SYK, BTK and multiple phosphorylation
  events in STAT5, AKT and MAPK pathways. Studies in the initial project period demonstrated
  that subsequent engagement of the pre-BCR linker molecule SLP65 results in global
  de-phosphorylation in the STAT5, AKT and MAPK pathways, cell cycle arrest and differentiation
  of pre-B into mature B cells [].
pmcid: PMC4136419
papertitle: Targeting the B cell receptor signaling pathway in B lymphoid malignancies.
reftext: Maike Buchner, et al. Curr Opin Hematol. ;21(4):341-349.
pmc_ranked_result_index: '70422'
pathway_score: 0.8603443
filename: nihms603930f2.jpg
figtitle: Targeting the B cell receptor signaling pathway in B lymphoid malignancies
year: ''
organisms: Homo sapiens
ndex: 4dedc6b6-df1f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4136419__nihms603930f2.html
  '@type': Dataset
  description: Pro-B cells (Fraction B) proliferate under the influence of the IL7
    receptor (activation of JAK-STAT5, AKT) until they rearrange Ig VH-DJH gene segments
    to express a functional μ heavy chain (μ HC) as part of the pre-BCR (Fraction
    C’). Upon initial cell surface expression (Fraction C’), autonomous pre-BCR signaling
    induces strong proliferation via activation of SRC kinases (Lyn), SYK, BTK and
    multiple phosphorylation events in STAT5, AKT and MAPK pathways. Studies in the
    initial project period demonstrated that subsequent engagement of the pre-BCR
    linker molecule SLP65 results in global de-phosphorylation in the STAT5, AKT and
    MAPK pathways, cell cycle arrest and differentiation of pre-B into mature B cells
    [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAG1
  - SLC25A3
  - MAPK3
  - MYC
  - MAPK1
  - AKT1
  - IL7
  - MAPK13
  - MAPK12
  - BTK
  - CCND2
  - MAPK14
  - RAG2
  - STAT5A
  - JAK2
  - MAPK10
  - AKT3
  - SYK
  - BLNK
  - TYK2
  - MAPK11
  - MAPK9
  - JAK3
  - STAT5B
  - JAK1
  - MAPK8
  - LYN
  - BACH2
  - TNFSF14
  - AKT2
  - Cancer
genes:
- word: Rag1,Rag2
  symbol: RAG1
  source: hgnc_symbol
  hgnc_symbol: RAG1
  entrez: '5896'
- word: pHC
  symbol: PHC
  source: hgnc_prev_symbol
  hgnc_symbol: SLC25A3
  entrez: '5250'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Myc,
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IL7
  symbol: IL7
  source: hgnc_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: Ccnd2
  symbol: CCND2
  source: hgnc_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Rag1,Rag2
  symbol: RAG2
  source: hgnc_symbol
  hgnc_symbol: RAG2
  entrez: '5897'
- word: Stat5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: BLNK
  symbol: BLNK
  source: hgnc_symbol
  hgnc_symbol: BLNK
  entrez: '29760'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Stat5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: Bach2
  symbol: BACH2
  source: hgnc_symbol
  hgnc_symbol: BACH2
  entrez: '60468'
- word: light
  symbol: LIGHT
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF14
  entrez: '8740'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4136419__F2
redirect_from: /figures/PMC4136419__F2
figtype: Figure
---
